Ireland: AstraZeneca plans advanced manufacturing facility in Ireland

Biopharmaceutical giant, AstraZeneca, has plans to establish its first manufacturing facility in near Dublin, Ireland, a next-generation active pharmaceutical ingredient (API) production establishment for small molecules. At an expected cost of US$360m, the new plant will allow for late-stage development and early commercial supply, using state of the art process technology and digital innovation designed…

You must be a HMI Subscriber to view this content.

Subscribe Now »